To learn more about who is eligible to participate, please visit the Johns Hopkins SKCCC Clinical Trials website or email email@example.com.
Believe Big is excited to be in the trenches with cancer research. We are supporting Johns Hopkins University School of Medicine to develop the first clinical trial in the United States using intravenous Mistletoe. This clinical trial brings together the conventional and complementary medical communities to fight cancer.
Mistletoe treatment for cancer is used widely in Germany and Switzerland, but in the United States, every potential treatment must be studied in a series of steps, called phases. Each phase is designed to answer a separate research question. The Mistletoe clinical trial at Johns Hopkins will be a Phase 1 trial, in which researchers will be testing the drug on a small group of participants to evaluate safety, determine a safe dose, and identify side effects. This is the first step of many research steps before mistletoe can be considered for conventional use in cancer treatment.
Due to the high level of interest in the study, we are assessing eligibility for the study in advance of a visit to Johns Hopkins. If you think you are eligible, please provide a copy of your most recent oncologist’s note, lab work, and imaging results. Please email documents to: firstname.lastname@example.org or call 410-502-5140 for mailing address.
To find out more about Mistletoe in science and medicine click here.